Participant Demographics
Authors: Ashley J. Zahabian, Myles A. Ingram*
* Statistics were calculated by Myles A. Ingram, M.S. in Data Science at Columbia University.
Name: J* Martin
Sex: Female
Gender: Female
Age: 27 years old
Diagnosis: Diagnosed with Borderline Personality Disorder
Ethnicity: Native American
Medications: No medications during Integrate BPD, just vitamin supplements. Has previously tried Celexa, Zoloft, Effexor, Wellbutrin, Lamictal, Abilify, Topamax but ended all medications in 2019 prior to Integrate BPD.
Concurrent therapy: None (CBT, DBT, and BetterHelp prior – ended all concurrent therapies in 2020).
Duration of Reality Integration Therapy™ (RIT): 6/16/2023 – 2/16/2024
8—Month Progress Overview in Integrate BPD
Study design: Throughout the Integrate BPD program, the participant completed surveys every month for 7 months to track their progress and measure changes in symptoms related to Borderline Personality Disorder (BPD). Each survey included 4-5 questions focused on the nine criteria of BPD: fear of abandonment, unstable relationships, identity disturbance, impulsivity, suicidal behavior, emotional instability, chronic feelings of emptiness, inappropriate anger, and stress-related paranoia or dissociation. The responses were then averaged to generate individual symptom scores, which were further averaged to create a composite score. This approach provided a comprehensive overview of each participant’s progress, allowing us to assess the program’s effectiveness in addressing core BPD symptoms over time.
** These scores are not intended for diagnosis and were developed by Integrate exclusively for research and progress measurement purposes.